Article Text
Letter
Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation
Statistics from Altmetric.com
Footnotes
Funding The clinical part of this study was partially financed by Abbott. This investigation was also facilitated by the Clinical Research Bureau of the Jan van Breemen Institute and received financial support from the Dutch Arthritis Foundation.
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.